Cassava Sciences Inc Shares Close the Day 13.5% Lower - Daily Wrap
The company saw its shares close the day 13.5% lower than yesterday, with trading volume lower than its 30 day average.
Apr 08, 2021 by Kwhen Finance Editors
Cassava Sciences Inc shares closed today 13.5% lower than it did at the end of yesterday. The stock is currently up 509.5% year-to-date, up 764.2% over the past 12 months, and up 178.8% over the past five years. Today, the Dow Jones Industrial Average fell 0.1%, and the S&P 500 rose 0.0%.
Trading Activity
- Shares traded as high as $44.73 and as low as $35.75 this week.
- Shares closed 7e+1% below its 52-week high and 2e+3% above its 52-week low.
- Trading volume this week was 34.5% lower than the 10-day average and 69.9% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 2.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cassava Sciences Inc | -13.5 | 509.5 | 764.2 | ||
| Dow Jones Industrial Average | -0.1 | 10.9 | 45.2 | -0.2 | 50.6 |
| S&P 500 Index | 0.0 | 10.5 | 50.3 | -0.3 | 53.5 |
| Health Care | 0.1 | 4.0 | 28.2 | -1.4 | 27.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 949.5%
- The company's stock price performance over the past 12 months beats the peer average by 810.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cassava Sciences Inc | SAVA | 0 | 509.5 | 764.2 | ||
| Peer Avg | N/A | 0 | 48.5 | 84.0 | -27.4 | 187.4 |
| Ocular Therapeutix Inc | OCUL | 0 | -20.2 | 204.6 | -32.1 | 246.6 |
| OncoCyte Corp | OCX | 0 | 122.4 | 117.8 | -18.0 | 368.7 |
| Oragenics Inc. | OGEN | 0 | 92.0 | 13.5 | -59.6 | 134.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?